When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions FDA Poised to Ease Restrictions on Injectable Peptides Af The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157: The peptide with big claims and scant evidence STAT BPC 157 FDA approval status 2026: Is it legal? Veedma